Skip to content

Vericel VCEL Interest coverage

Interest coverage at other companies

Stryker logo
StrykerSYK
-3.0×
LeMaitre Vascular logo
LeMaitre VascularLMAT
14.1×-21.4×
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
-35.5×
Globus Medical logo
Globus MedicalGMED
42.4×
Johnson & Johnson logo
Johnson & JohnsonJNJ
24.5×-1.7×

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.13B-26.8%

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Calculated from Vericel’s reported figures.

Based on trailing twelve months.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's interest coverage?
Vericel (VCEL) reported interest coverage of 24.8× in Q1 2026.
How has Vericel's interest coverage changed year-over-year?
Vericel's interest coverage increased by 641.2% year-over-year, from -4.6× to 24.8×.
What is the long-term trend for Vericel's interest coverage?
Over 2 years (2020 to 2025), Vericel's interest coverage has grown at a -78.9% compound annual growth rate (CAGR), from 395.3× to 17.5×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.